Peter Lelkes, PhD
Peter Lelkes, PhD

Thank you for your interest in our now six years young department. There is a lot of good news to talk about here at Temple Bioengineering, the first of which is the most exciting: ABET has accredited our Bachelor of Science program, retroactively, which includes the first cohorts of our graduates. The next ABET accreditation for the Bioengineering program is scheduled for academic year 2023/2024. 

The quality of our program was evident even before this wonderful news. We have experienced continued growth, both in terms of the numbers of undergraduates entering our program, and also the number of bioengineering students who graduated from our undergraduate and graduate programs. The SAT scores of our incoming freshmen are at an all-time high. Many of our graduates have gone on to employment in industry and academia, while others continue their post-graduate education in prestigious graduate school or medical school programs across the country. 

For example, we have 74 new undergraduate students (an increase by about 20% vs the previous year) out of a total of 277 undergraduates, and a total of 42 graduate students (29 PhD, 13 MS); five of those MS students are  (4+1) students). In the same period, we graduated 50 undergraduates, 12 PhD Students  and 10 MS students.

We also recently hired three new faculty: Dr. Karin Wang, Assistant Professor on tenure track, whose work focuses on cancer bioengineering and cancer-cell ECM interactions, and Drs. Jonathan Gerstenhaber and James Furmato, instructional faculty on non-tenure track, who already significantly impacted our educational mission.

Please browse some of the news that comes out of our department, our students and faculty continue to leverage state-of-the-art engineering tools to asking and solving fundamental-and translational bioengineering questions and improving the quality of life in areas such as innovative medical devices and diagnostic equipment, smart biomaterials, novel bioimaging modalities to detect and predict diseases such as cancer. This past spring and summer, the research of our faculty was recognized by a number of prestigious federal and foundation grants and resulted in 20 peer-reviewed publications.

While we are excited about our achievements, we look forward to continuing to making further significant progress in the coming years.

Peter I. Lelkes
Laura H. Carnell Professor and Chair